You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | 1.6% | 9.9% |
| ROCE | 2.8% |
| Latest | Forecast | |
|---|---|---|
| P/E | -1,030.0 | 13.6 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 1.9 | 1.3 |
| Price / Book value | 3.3 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 78.9% | -30.2% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | -61.9% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (€m) |
Pre-tax (€m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | 17.41 | -1.80 | €-0.03 | -4.7 | 0.0 | n/a | n/a | 0.0% |
| 2018-12-31 | n/a | -1.66 | €-7.85 | 0.0 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | 3.37 | -5.81 | -3.48p | -1.3 | 0.0 | n/a | n/a | 0.0% |
| 2020-12-31 | 20.60 | -10.98 | -1.80p | -14.3 | 0.0 | n/a | n/a | 0.0% |
| 2021-12-31 | 36.86 | 0.28 | -0.01p | -2,300.0 | 0.0 | n/a | n/a | 0.0% |
| Open Orphan wins £7.2m contract for RSV human study Sharecast News | 14 Jun |
|---|---|
| Open Orphan wins £7.3m human flu study contract Sharecast News | 18 May |
| Open Orphan wins £5m contract for human study in RSV Sharecast News | 25 Mar |
| £6.2m Influenza human challenge study contract | 04-Aug-22 07:00 |
|---|---|
| Result of AGM | 05-Jul-22 13:19 |
| Omicron human challenge model | 30-Jun-22 07:01 |
| £7.2m RSV human challenge study contract | 14-Jun-22 07:00 |
| Board appointment amendment | 10-Jun-22 12:16 |